Nevertheless, the first study of CH in SCD identified and confirmed the presence of CH, including high-risk clones with somatic variants in TP53 in young individuals (<40), an age at which no CH is typically detected with the sequencing method used [106]. The gene discussed is TP53; the disease is cyclic hematopoiesis.